BBIO
BridgeBio Pharma
BBIO
Meridian score46
ResearchNot researched
4 of 5 factors measured. Quality is not measured for this company.
QualityNo data
MomentumMomentum: 35th percentile
GrowthGrowth: 99th percentile
ValuationValuation: 0th percentile
ExpectationsExpectations: 2nd percentile
Evidence to review
- Financial comparability: Growth comparisons span material statement or share-base changes.
- Financial comparability: Operating profitability improved but remains weak, with a net loss.
Price and trend
Price$69.37
1M+4.1%
3M-17.0%
6M-0.5%
52w position34.4%
From high-25.7%
Relative volume0.8x
As ofOct 27, 2026
Above 21d: yesAbove 50d: noAbove 200d: no50d over 200d: no